Skip to content

Press

Portfolio-Media Coverage
SURGE – This Startup Just Raised $32 Million To Keep Cancers From Recurring After Surgery
July 19, 2023 Jul 19, 2023 Forbes
Portfolio-Media Coverage
Surge Therapeutics Raises $32M in Series B Financing
July 19, 2023 Jul 19, 2023 FinSMEs
Portfolio-Media Coverage
July 19 Quick Takes: Surge Therapeutics Inc. raised a $32 million series B round
July 19, 2023 Jul 19, 2023 Biocentury
Portfolio-Press Releases
Recode Therapeutics Appoints Erica Jefferson as Senior Vice President of Corporate Affairs
July 10, 2023 Jul 10, 2023
Portfolio-Media Coverage
ReCode–a New Contestant in the mRNA Race
May 22, 2023 May 22, 2023 Biospace
Portfolio-Media Coverage
Nido Bio: treating neurodegeneration with small molecules
May 17, 2023 May 17, 2023 Biocentury
Portfolio-Press Releases
Ensoma Closes Series B Extension, Bringing Total Round to $135 Million
May 16, 2023 May 16, 2023
Portfolio-Media Coverage
Nido Biosciences raises $109m in funding for neurological diseases treatments
May 16, 2023 May 16, 2023 PharmaFile
Portfolio-Media Coverage
Nido Bio – 5AM Ventures leads $109 million bet on precision drug start-up
May 16, 2023 May 16, 2023 PharmaLetter
Portfolio-Press Releases
Nido Biosciences Emerges as Clinical Stage Company Raising $109 Million to Advance Treatments for Debilitating Neurological Diseases
May 15, 2023 May 15, 2023